Thomas R. Duquin, MD; Program Co-Chair
Jennifer Tangtiphaiboontana, MD; Program Co-Chair
Joaquin Sanchez-Sotelo, MD, PhD; 2024 – 2025 ASES President
March 6, 2026 | Morial Convention Center, Rm 343-345 | New Orleans, LA | During the 2026 AAOS Annual Meeting
The ASES Specialty Day provides a unique opportunity for shoulder and elbow surgeons to learn firsthand from national and international leaders in the field. This year’s program will include lively debates, discussions, and case presentations covering an array of topics, including tendon tears, fractures, instability, arthritis, and basic science.
Learning Objectives
Upon completion of this CME activity, participants will be able to:
- Identify opportunities to implement evidence-based techniques into current practice.
- Discuss options for the treatment of complex shoulder and elbow disorders.
- Identifying strategies for improved surgical techniques and the use of appropriate technology in the treatment of the shoulder and elbow.
- Identify and evaluate approaches to improve assessment and management of elbow and shoulder disorders in the clinical setting.
- Discuss approaches to enhance the clinical diagnosis of shoulder and elbow disorders.
CME Accreditation Statement
The 2026 ASES Specialty Day has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Orthopaedic Surgeons and the American Shoulder and Elbow Surgeons.
Please note that the amount of CME credit for the 2026 ASES Specialty Day, Friday, March 6, 2026, in New Orleans, Louisiana (live activity) has been designated for a maximum of 5.5 AMA PRA Category 1 Credits™
Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure of Relevant Financial Relationships
Many faculty members have financial relationships with ineligible companies. An ineligible company is
defined as those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. To ensure that these relationships do not influence our accredited educational activity, ASES requires all faculty members to disclose all relevant financial relationships with any ineligible company(ies) within the past 24 months. Disclosure includes documentation of the name of the ineligible company and the nature of the relationship. ASES subsequently identifies relevant financial relationships and mitigates such relationships prior to the individual assuming their role. All conflicts of interest potentially impacting educational content have been resolved prior to this course. Disclosure of identified financial relationships is disclosed to all learners prior to engaging in this activity.
All relevant financial relationships have been mitigated.
See the 2026 AAOS Annual Meeting Page for details and updates.
Questions about the AAOS meeting? Contact AAOS Customer Service at (800) 626-6726 or meeting@aaos.org.